🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: The primary objective of the study is to characterize p...
Status
Completed
Location
Investigational Site Number : 0320005
Start Date
2020-11-02
Trial ID
NCT04550962
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab administered ever...
Status
Completed
Location
SEC Clinical Research, LLC-Site Number:8400030
Start Date
2019-04-15
Trial ID
NCT03930732
The primary purpose of this study is to evaluate the safety, tolerability, ...
Status
Active Not Recruiting
Location
Investigational Site
Start Date
2025-06-04
Trial ID
NCT07027527
Primary Objective: To evaluate the effect of dupilumab, compared to placeb...
Status
Completed
Location
Investigational Site Number 840402
Start Date
2016-01-27
Trial ID
NCT02573233
Primary objective: To assess the disease control of moderate to severe ato...
Status
Completed
Location
Investigational site Kuwait
Start Date
2022-01-18
Trial ID
NCT05214326
Primary Objective: To describe the long-term safety of dupilumab in treatm...
Status
Completed
Location
Investigational Site Number :840099
Start Date
2018-08-30
Trial ID
NCT03620747
Treatments Being Tested
Primary Objective: * To evaluate the efficacy of treatment with dupilumab ...
Status
Completed
Location
Asthma Allergy & Immunology Clinical Research Unit Site Number : 8400001
Start Date
2020-12-01
Trial ID
NCT04684524
Treatments Being Tested
Primary Objective: Part A * To quantify deficits in cognitive functioning ...
Status
Completed
Location
Clinical Research Center of Alabama, LLC
Start Date
2022-01-27
Trial ID
NCT05203380
Treatments Being Tested
This study will evaluate upadacitinib compared to dupilumab (Dupixent®) in ...
Status
Completed
Location
Clinical Research Center AL /ID# 210277
Start Date
2019-02-21
Trial ID
NCT03738397
Treatments Being Tested
This is a phase 1, single subcutaneous dose study to evaluate safety and ph...
Status
Completed
Location
Prism Research-Site Number:840002
Start Date
2014-11-02
Trial ID
NCT05976360
Treatments Being Tested